Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using pulsed radiofrequency and platelet-rich plasma to treat glossopharyngeal neuralgia

Official title: Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Platelet Rich Plasma, to the Treatment of Idiopathic Glossopharyngeal Neuralgia (GPN): A Study Protocol for a Multi-Center, Prospective, Open-Label, Propensity Score Match Cohort Study

Run by Beijing Tiantan Hospital · NCT06931457 · Data updated 2026-11-12

This study is testing if combining pulsed radiofrequency treatment with platelet-rich plasma can help adults with glossopharyngeal neuralgia who haven't found relief from medications.

More Platelet Rich Plasma trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment121 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMay 1, 2025
Main results expectedMay 1, 2027
Study endsJune 1, 2027
Registry record updatedJuly 3, 2025
Trial IDNCT06931457 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 diagnosed with idiopathic GPN who have not responded to or cannot tolerate conventional medications.

Probably not a fit

Patients with bilateral GPN or those with significant medical contraindications such as infections or previous mental illness may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness and safety of combining pulsed radiofrequency (PRF) treatment with platelet-rich plasma (PRP) for patients suffering from idiopathic glossopharyngeal neuralgia (GPN). Participants must be over 18 years old and have previously failed pharmacotherapy or experienced intolerable side effects from medications. The study will monitor patients undergoing PRF treatment for GPN, with follow-up assessments conducted for at least one month to evaluate outcomes. The goal is to determine if this combined approach can provide better relief from symptoms compared to standard treatments.

Why it matters

Potential benefit: If successful, this approach could offer a new, effective treatment option for patients suffering from glossopharyngeal neuralgia.

How similar studies have gone: While the combination of PRF and PRP is a novel approach, similar studies have shown promise in treating other neuralgias, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age \>18 years;
2. diagnosed with idiopathic GPN according to the third International Classification of Headache Disorders (ICHD) classification;
3. patients who failed pharmacotherapy or intolerable side effects of medication;
4. undergoing PRF for GPN;
5. at least 1 month of follow-up recordings.

Exclusion Criteria:

1. Patients with bilateral GPN;
2. Abnormalities in blood measurements, liver and kidney function, blood glucose, coagulation, electrocardiography or chest radiography;
3. Infection at the puncture site;
4. Previous mental illness;
5. Previous history of narcotic drug abuse;
6. Prior anticoagulant or antiplatelet therapy;
7. An implantable pulse generator;
8. Current pregnancy or breast feeding.
9. Patients with incomplete medical records (lack of baseline data or postoperative follow-up data).

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.